A Budget Impact Model Estimating the Financial Impact of Increased Use of Generic Bortezomib Intravenous (Iv) in the Treatment of Relapsed/Refractory Multiple Myeloma (Mm) in Venezuela
Abstract
Authors
EA Wehler S Kowal CA Obando D Muschett JA de Anda P Anaya J Munakata L Gonzalez